Life Sciences Insights

CLS

Meet the California Life Sciences FAST Fall 2026 Cohort

AdvocacyCLSIndustry

Where Progress Lives: This Month in California Life Sciences August 2026

Is Your Data AI-Ready? A Practical Checklist for Life Sciences Orgs

Search

Search
Categories
  • Member Voice (66)
  • CLS (13)
  • Industry (12)
  • Innovation (4)
  • Advocacy (3)
  • Events (3)
Contributors
  • Abalone Bio (1)
  • Accelero Biostructures (1)
  • AstraZeneca (1)
  • Avance Clinical (1)
  • Battelle (1)
  • Biointron (2)
  • Biotech Connection LA (1)
  • Boehringer Ingelheim USA (1)
  • Brainstorm Therapeutics (1)
  • Centogene (4)
  • CleanSpace (6)
  • Digital Science (3)
  • Eppendorf (1)
  • Fenix Group (1)
  • Flannery Sales Systems (4)
  • Germfree (1)
  • Grace Lillie (1)
  • Hogan Lovells (1)
  • Katalyze AI (1)
  • Labcon (1)
  • Life Science Nation (1)
  • MabPlex (3)
  • MBC BioLabs (1)
  • Medscape (3)
  • Mike Guerra (6)
  • Nucleus Biologics (1)
  • Oncotelic (1)
  • Origami Therapeutics (1)
  • Plantibodies (1)
  • Procopio (1)
  • Project Outlier (1)
  • Royale International (8)
  • SankerIP (1)
  • Saskia Hoving (1)
  • Springer Nature (1)
  • SU Group (1)
  • Synfini (1)
  • Synlico (1)
  • Withum (1)
  • Yali Biosciences (1)
CLS

Meet the California Life Sciences FAST Fall 2026 Cohort

Fall 2026 FAST companies span cell therapy, drug discovery, rare disease, medical devices, and neuroscience, reflecting the depth and diversity...

Member Voice

Transforming Neurotherapeutic Discovery With AI and Human Brain Organoids

Brainstorm Therapeutics

Brain organoids and AI are reshaping neurotherapeutic discovery. BrainStorm Therapeutics on patient-derived mini-brains, Parkinson’s, and 90% trial failure.

Advocacy CLS Industry

Where Progress Lives: This Month in California Life Sciences August 2026

Mike Guerra

Each month, California Life Sciences (CLS) President and CEO Mike Guerra shares what’s shaping the life sciences industry, highlights the...

Innovation Member Voice

AI Drug Discovery & Development for DNA Damage Response (DDR) Oncology Therapeutics

Accelero Biostructures

AI drug discovery depends on the data behind it. Accelero Biostructures on generating proprietary protein-ligand data to reach ‘undruggable’ DDR...

Is Your Data AI-Ready? A Practical Checklist for Life Sciences Orgs

Data hygiene is important but AI-readiness in life sciences starts with data rights. Six checks covering consent, ownership, and provenance,...

Member Voice

From Data to Discovery in AI-Driven Life Sciences R&D

Saskia Hoving

AI-driven life sciences R&D turns information overload into insight through text mining, generative AI, and APIs, plus the responsibility questions...

Advocacy CLS

From the Lab to the Clinic: Center Forward Healthcare Innovation Conference

California’s life sciences ecosystem was on full display as we joined Center Forward and congressional staff for a week of...

Member Voice

Align Sales and Marketing Teams on Lead Qualification Criteria

Flannery Sales Systems

How valuable are marketing qualified leads (MQLs) to your organization? MQLs are incoming leads generated by your marketing department, usually...

Member Voice

Causal Graphs: A Blueprint Driving Drug Discovery From Single-Cell Omics

Synlico

Causal graphs move drug discovery beyond correlation, using single-cell omics from 100 million cells to find the true drivers of...